News
A new ICES study has found that 1.74 million patients in Ontario are attached to family physicians aged 65 or older, and that ...
Investigating tirzepatide's role in Alzheimer's reveals its potential to improve brain function and reduce inflammation, ...
Qureight's synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment
Qureight, a deep-learning analytics company accelerating drug development through AI-powered data curation, today announced that its digitally-twinned synthetic control arm has been used in a ...
Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis and isolation, today ...
Evosep, a global leader in robust, high-throughput proteomics technologies, has been selected as the proteomics platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results